Skip to main content
. 2015 Jan 18;20(2):145–152. doi: 10.1016/j.rpor.2014.12.002

Table 1.

PTV coverage for each patient for HT and LINAC respectively.

Dose to PTV D(V99) [%]
D(V98) [%]
D(V95) [%]
D(V1) [%]
Dmean [%]
Dmax [%]
Dmin [%]
SD [Gy]
Device HT LINAC HT LINAC HT LINAC HT LINAC HT LINAC HT LINAC HT LINAC HT LINAC
Patient 1 98.4 94.4 99.4 96.1 100.2 97.5 105.5 107.2 102.0 100.1 111.0 109.8 58.8 77.3 0.4 0.6
Patient 2 93.1 94.8 95.5 95.6 97.5 96.4 103.8 102.6 100.3 100.9 106.8 109.1 55.7 76.4 0.7 0.6
Patient 3 93.9 93.1 96.1 95.0 97.9 97.0 103.5 105.9 100.3 101.3 108.5 108.8 68.8 77.8 0.6 0.8